WHO Reports High Mortality Rate in Recent Ebola Outbreak in Congo
The WHO reports a high mortality rate in Congo's Ebola outbreak, with 31 out of 38 cases resulting in death. Rapid spread and vaccination efforts are ongoing to control the virus.
The World Health Organization (WHO) has announced a concerning escalation in the ongoing Ebola outbreak in southern Congo. Out of 38 confirmed cases, 31 have unfortunately resulted in fatalities, indicating a nearly 82% death rate. The outbreak, which was recently identified in the locality of Bulape in Kasai province near Angola, has been spreading rapidly with the number of casualties increasing significantly since last week.
Since the emergence of the outbreak, more than 900 contacts have been identified, highlighting the extensive reach of the disease in the region. Emergency vaccination campaigns have been underway since Sunday, with over 500 health care workers and contacts receiving the vaccine to help contain the spread and protect frontline responders.
Authorities initially reported the outbreak on September 5, and since then, the disease has expanded from two districts to four. logistical challenges, including transportation difficulties and limited storage infrastructure in Bulape, have slowed the vaccination efforts. Despite these obstacles, additional vaccine batches approved by the International Coordinating Group on Vaccine Provision are expected to arrive from Friday through Sunday to bolster response efforts.
The rapid spread and high mortality underscore the urgency of containment measures and continued vaccination efforts to prevent further deaths. WHO officials remain committed to supporting local health authorities in combating this deadly virus.
Source: https://medicalxpress.com/news/2025-09-ebola-cases-congo-resulted-deaths.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Potential Impact of Federal Policy Changes on HIV Prevention and Care in the United States
Recent federal policy proposals threaten to undermine HIV prevention and care efforts in the U.S., risking increased infections and treatment disruptions amid funding uncertainties.
New Oral Drug Offers Diabetes and Weight Loss Treatment Without Muscle Loss
A groundbreaking oral medication is being developed to treat type 2 diabetes and obesity without the muscle loss commonly associated with existing drugs like Ozempic, offering hope for safer, more effective therapies.
Breakthrough Gene Therapy Shows Promise for Recessive Dystrophic Epidermolysis Bullosa Patients
A new gene therapy using prademagene zamikeracel shows promising results in improving wound healing and reducing pain in patients with recessive dystrophic epidermolysis bullosa, a severe genetic skin disorder.
New Study Links Cholesterol Accumulation in Liver Lipid Droplets to Fibrosis in Metabolic Disease
New research shows that cholesterol accumulation within liver fat droplets directly promotes fibrosis in metabolic diseases, opening new therapeutic possibilities.